| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F3 Transcription Factor | 33 | 2019 | 46 | 5.800 |
Why?
|
| E2F Transcription Factors | 31 | 2019 | 48 | 4.000 |
Why?
|
| Retinoblastoma Protein | 28 | 2022 | 75 | 3.410 |
Why?
|
| E2F1 Transcription Factor | 27 | 2019 | 44 | 3.410 |
Why?
|
| PTEN Phosphohydrolase | 17 | 2022 | 108 | 3.140 |
Why?
|
| Repressor Proteins | 14 | 2019 | 183 | 3.010 |
Why?
|
| Cell Cycle | 28 | 2022 | 312 | 2.970 |
Why?
|
| E2F2 Transcription Factor | 20 | 2019 | 29 | 2.910 |
Why?
|
| Cell Proliferation | 34 | 2021 | 1174 | 2.790 |
Why?
|
| Cell Cycle Proteins | 29 | 2022 | 230 | 2.710 |
Why?
|
| Mice | 114 | 2023 | 8474 | 2.480 |
Why?
|
| Transcription Factors | 28 | 2019 | 753 | 2.230 |
Why?
|
| Animals | 141 | 2023 | 20881 | 2.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 12 | 2021 | 90 | 2.020 |
Why?
|
| Signal Transduction | 37 | 2022 | 2689 | 1.650 |
Why?
|
| Mice, Knockout | 37 | 2020 | 1692 | 1.560 |
Why?
|
| Mammary Neoplasms, Experimental | 10 | 2018 | 114 | 1.470 |
Why?
|
| Apoptosis | 26 | 2020 | 1641 | 1.470 |
Why?
|
| E2F7 Transcription Factor | 9 | 2016 | 15 | 1.440 |
Why?
|
| Embryonic Development | 9 | 2018 | 100 | 1.430 |
Why?
|
| Gene Expression Regulation | 21 | 2019 | 1293 | 1.430 |
Why?
|
| Placenta | 11 | 2019 | 101 | 1.430 |
Why?
|
| Liver Neoplasms | 4 | 2022 | 334 | 1.390 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 163 | 1.390 |
Why?
|
| Epithelial Cells | 11 | 2019 | 431 | 1.380 |
Why?
|
| Breast Neoplasms | 19 | 2022 | 1536 | 1.370 |
Why?
|
| DNA-Binding Proteins | 24 | 2013 | 700 | 1.320 |
Why?
|
| Pancreatic Neoplasms | 6 | 2023 | 332 | 1.300 |
Why?
|
| Fibroblasts | 24 | 2023 | 902 | 1.280 |
Why?
|
| Cell Differentiation | 15 | 2019 | 1034 | 1.260 |
Why?
|
| Embryo, Mammalian | 12 | 2015 | 176 | 1.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2021 | 756 | 1.160 |
Why?
|
| Trophoblasts | 8 | 2021 | 29 | 1.160 |
Why?
|
| Cell Transformation, Neoplastic | 12 | 2023 | 235 | 1.090 |
Why?
|
| Stromal Cells | 12 | 2022 | 113 | 1.090 |
Why?
|
| Neoplasm Proteins | 9 | 2018 | 307 | 1.080 |
Why?
|
| Chromatin Immunoprecipitation | 7 | 2017 | 52 | 1.060 |
Why?
|
| S Phase | 11 | 2014 | 38 | 0.990 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2022 | 231 | 0.960 |
Why?
|
| Carrier Proteins | 18 | 2014 | 597 | 0.910 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2018 | 44 | 0.870 |
Why?
|
| Pancreas | 3 | 2023 | 225 | 0.870 |
Why?
|
| Endometrial Neoplasms | 2 | 2020 | 69 | 0.850 |
Why?
|
| Gene Deletion | 15 | 2018 | 235 | 0.850 |
Why?
|
| E2F4 Transcription Factor | 6 | 2019 | 9 | 0.840 |
Why?
|
| Genome | 3 | 2018 | 54 | 0.840 |
Why?
|
| Tumor Suppressor Proteins | 12 | 2010 | 194 | 0.840 |
Why?
|
| Capsid Proteins | 12 | 2001 | 27 | 0.830 |
Why?
|
| Mice, Transgenic | 25 | 2018 | 1033 | 0.830 |
Why?
|
| Macrophages | 7 | 2017 | 647 | 0.810 |
Why?
|
| Viral Proteins | 13 | 2001 | 150 | 0.810 |
Why?
|
| Neoplasms | 7 | 2020 | 1667 | 0.790 |
Why?
|
| Alleles | 6 | 2016 | 386 | 0.780 |
Why?
|
| Cell Division | 17 | 2022 | 541 | 0.770 |
Why?
|
| Promoter Regions, Genetic | 19 | 2019 | 615 | 0.760 |
Why?
|
| Cyclin-Dependent Kinases | 12 | 2003 | 60 | 0.750 |
Why?
|
| Cell Survival | 15 | 2021 | 901 | 0.750 |
Why?
|
| Carcinoma | 4 | 2022 | 215 | 0.740 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2020 | 4 | 0.740 |
Why?
|
| Phenylthiohydantoin | 1 | 2020 | 12 | 0.730 |
Why?
|
| ras Proteins | 3 | 2022 | 102 | 0.730 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 2550 | 0.720 |
Why?
|
| Nitriles | 1 | 2020 | 68 | 0.720 |
Why?
|
| DNA | 6 | 2017 | 597 | 0.710 |
Why?
|
| Intestine, Small | 3 | 2016 | 89 | 0.700 |
Why?
|
| Transcriptome | 4 | 2019 | 164 | 0.700 |
Why?
|
| Female | 59 | 2022 | 38074 | 0.680 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.670 |
Why?
|
| Transcription, Genetic | 15 | 2019 | 562 | 0.660 |
Why?
|
| Reoviridae | 9 | 2001 | 14 | 0.660 |
Why?
|
| Mammary Glands, Animal | 6 | 2018 | 71 | 0.650 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 332 | 0.650 |
Why?
|
| Origin Recognition Complex | 2 | 2018 | 5 | 0.650 |
Why?
|
| Endoreduplication | 1 | 2018 | 3 | 0.640 |
Why?
|
| Tumor Microenvironment | 9 | 2022 | 213 | 0.640 |
Why?
|
| Cells, Cultured | 18 | 2019 | 2673 | 0.630 |
Why?
|
| Genes, myc | 3 | 2016 | 26 | 0.620 |
Why?
|
| CDC2-CDC28 Kinases | 6 | 2002 | 17 | 0.610 |
Why?
|
| Chromatin | 4 | 2022 | 76 | 0.600 |
Why?
|
| Cell Line, Tumor | 21 | 2022 | 1851 | 0.590 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 18 | 0.570 |
Why?
|
| MicroRNAs | 6 | 2020 | 447 | 0.570 |
Why?
|
| Stem Cells | 5 | 2016 | 248 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 20 | 2021 | 2791 | 0.570 |
Why?
|
| Gene Dosage | 1 | 2017 | 47 | 0.570 |
Why?
|
| Carcinogenesis | 7 | 2023 | 124 | 0.570 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 68 | 0.570 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 7 | 2016 | 49 | 0.560 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 94 | 0.550 |
Why?
|
| Cell Nucleus | 6 | 2022 | 305 | 0.550 |
Why?
|
| Humans | 85 | 2022 | 68618 | 0.540 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2016 | 320 | 0.520 |
Why?
|
| Pregnancy | 13 | 2021 | 2334 | 0.520 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 37 | 0.510 |
Why?
|
| Genes, Retinoblastoma | 4 | 2016 | 4 | 0.500 |
Why?
|
| Software | 2 | 2017 | 418 | 0.500 |
Why?
|
| Nuclear Proteins | 10 | 2018 | 271 | 0.500 |
Why?
|
| Mutation, Missense | 1 | 2015 | 112 | 0.490 |
Why?
|
| Gene Expression Profiling | 10 | 2019 | 498 | 0.480 |
Why?
|
| Gene Knock-In Techniques | 2 | 2015 | 35 | 0.480 |
Why?
|
| Mesoderm | 4 | 2023 | 231 | 0.480 |
Why?
|
| Receptor, ErbB-2 | 2 | 2018 | 129 | 0.470 |
Why?
|
| Liver | 4 | 2022 | 1118 | 0.460 |
Why?
|
| Placentation | 2 | 2013 | 6 | 0.440 |
Why?
|
| Integrases | 3 | 2012 | 31 | 0.440 |
Why?
|
| DNA Replication | 7 | 2003 | 167 | 0.440 |
Why?
|
| Binding Sites | 5 | 2017 | 631 | 0.440 |
Why?
|
| Cell Line | 23 | 2021 | 1752 | 0.430 |
Why?
|
| Phenotype | 9 | 2017 | 947 | 0.430 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2017 | 328 | 0.430 |
Why?
|
| Cloning, Molecular | 8 | 2005 | 357 | 0.420 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 8 | 2014 | 51 | 0.410 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2018 | 29 | 0.400 |
Why?
|
| Cell Lineage | 4 | 2017 | 146 | 0.390 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 157 | 0.380 |
Why?
|
| Cyclins | 5 | 2019 | 50 | 0.380 |
Why?
|
| Protein Stability | 3 | 2019 | 90 | 0.380 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 9 | 0.380 |
Why?
|
| Multigene Family | 4 | 2019 | 93 | 0.370 |
Why?
|
| Phosphorylation | 12 | 2020 | 1200 | 0.370 |
Why?
|
| Mutation | 11 | 2022 | 1213 | 0.370 |
Why?
|
| Protein Binding | 10 | 2017 | 1027 | 0.370 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 597 | 0.370 |
Why?
|
| Central Nervous System | 3 | 2009 | 107 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 5 | 2009 | 97 | 0.360 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2022 | 21 | 0.360 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2012 | 268 | 0.360 |
Why?
|
| Hepatocytes | 3 | 2018 | 205 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2018 | 331 | 0.350 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 40 | 0.350 |
Why?
|
| Cyclin E | 6 | 2003 | 19 | 0.340 |
Why?
|
| Cyclin D1 | 3 | 2022 | 37 | 0.340 |
Why?
|
| DNA Damage | 6 | 2019 | 190 | 0.340 |
Why?
|
| Molecular Sequence Data | 17 | 2014 | 1447 | 0.340 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 22 | 0.340 |
Why?
|
| Fetus | 4 | 2019 | 157 | 0.340 |
Why?
|
| Lung Neoplasms | 4 | 2015 | 1173 | 0.340 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2022 | 46 | 0.330 |
Why?
|
| Embryo Loss | 6 | 2010 | 17 | 0.330 |
Why?
|
| Immunohistochemistry | 8 | 2019 | 1174 | 0.320 |
Why?
|
| Gene Expression | 8 | 2016 | 770 | 0.320 |
Why?
|
| Neoplastic Stem Cells | 4 | 2018 | 84 | 0.320 |
Why?
|
| Neural Stem Cells | 2 | 2022 | 32 | 0.320 |
Why?
|
| Growth | 1 | 2008 | 17 | 0.320 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 70 | 0.320 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2022 | 36 | 0.320 |
Why?
|
| Centrosome | 2 | 2010 | 6 | 0.310 |
Why?
|
| Base Sequence | 15 | 2014 | 1015 | 0.310 |
Why?
|
| Microscopy, Confocal | 5 | 2015 | 337 | 0.310 |
Why?
|
| Flow Cytometry | 7 | 2019 | 489 | 0.310 |
Why?
|
| Genotype | 4 | 2016 | 786 | 0.310 |
Why?
|
| Enzyme Activation | 5 | 2018 | 791 | 0.310 |
Why?
|
| Organ Specificity | 6 | 2017 | 167 | 0.310 |
Why?
|
| Lymphoma | 2 | 2007 | 116 | 0.300 |
Why?
|
| Diploidy | 1 | 2007 | 7 | 0.290 |
Why?
|
| Cell Movement | 5 | 2018 | 630 | 0.290 |
Why?
|
| Male | 24 | 2021 | 37321 | 0.290 |
Why?
|
| Ovarian Neoplasms | 3 | 2021 | 267 | 0.280 |
Why?
|
| G1 Phase | 7 | 2006 | 42 | 0.280 |
Why?
|
| Neovascularization, Physiologic | 4 | 2014 | 164 | 0.280 |
Why?
|
| Receptors, Virus | 4 | 1996 | 20 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2011 | 237 | 0.280 |
Why?
|
| Neoplasm Invasiveness | 4 | 2021 | 369 | 0.270 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2018 | 63 | 0.260 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 86 | 0.260 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2007 | 61 | 0.260 |
Why?
|
| NF-kappa B | 2 | 2017 | 432 | 0.250 |
Why?
|
| Disease Progression | 8 | 2019 | 1038 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 223 | 0.250 |
Why?
|
| S Phase Cell Cycle Checkpoints | 2 | 2015 | 4 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2022 | 689 | 0.240 |
Why?
|
| Trans-Activators | 2 | 2017 | 237 | 0.240 |
Why?
|
| RNA, Messenger | 11 | 2021 | 1664 | 0.240 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2022 | 9 | 0.240 |
Why?
|
| RNA, Neoplasm | 3 | 2018 | 76 | 0.240 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 215 | 0.240 |
Why?
|
| Inflammation | 4 | 2022 | 1030 | 0.240 |
Why?
|
| Gene Targeting | 4 | 2014 | 58 | 0.240 |
Why?
|
| Transfection | 10 | 2017 | 782 | 0.230 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 226 | 0.230 |
Why?
|
| Mitosis | 5 | 2018 | 76 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 710 | 0.230 |
Why?
|
| Protein Phosphatase 2 | 2 | 2021 | 67 | 0.230 |
Why?
|
| Mammals | 3 | 2022 | 47 | 0.230 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2003 | 14 | 0.230 |
Why?
|
| Tumor Burden | 2 | 2021 | 132 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2021 | 28 | 0.220 |
Why?
|
| Protein Kinases | 2 | 2017 | 122 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2015 | 94 | 0.220 |
Why?
|
| Blotting, Western | 8 | 2012 | 954 | 0.210 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 13 | 2001 | 15 | 0.210 |
Why?
|
| Adult Stem Cells | 1 | 2022 | 13 | 0.210 |
Why?
|
| Gene Silencing | 4 | 2010 | 137 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 331 | 0.210 |
Why?
|
| Endometrial Hyperplasia | 1 | 2022 | 4 | 0.210 |
Why?
|
| Protein Folding | 4 | 2001 | 82 | 0.200 |
Why?
|
| Endothelial Cells | 4 | 2020 | 384 | 0.200 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2021 | 3 | 0.200 |
Why?
|
| Oncogenes | 1 | 2022 | 71 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2019 | 284 | 0.200 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2021 | 4 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2004 | 114 | 0.200 |
Why?
|
| Caenorhabditis elegans | 2 | 2022 | 38 | 0.200 |
Why?
|
| Protein Biosynthesis | 6 | 2016 | 181 | 0.200 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2021 | 25 | 0.200 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 22 | 0.190 |
Why?
|
| Proteins | 3 | 2000 | 474 | 0.190 |
Why?
|
| DNA Methylation | 5 | 2007 | 193 | 0.190 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 48 | 0.190 |
Why?
|
| Homeostasis | 1 | 2023 | 291 | 0.190 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2003 | 17 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 74 | 0.180 |
Why?
|
| Response Elements | 2 | 2015 | 29 | 0.180 |
Why?
|
| Mammary Glands, Human | 2 | 2018 | 33 | 0.180 |
Why?
|
| Models, Biological | 6 | 2014 | 981 | 0.180 |
Why?
|
| Janus Kinase 2 | 2 | 2017 | 40 | 0.180 |
Why?
|
| Cyclin D | 1 | 2020 | 12 | 0.180 |
Why?
|
| Immunologic Surveillance | 2 | 2017 | 10 | 0.180 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 314 | 0.180 |
Why?
|
| Metaplasia | 2 | 2016 | 27 | 0.170 |
Why?
|
| Algorithms | 6 | 2013 | 1196 | 0.170 |
Why?
|
| Cell Communication | 2 | 2011 | 116 | 0.170 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2019 | 8 | 0.170 |
Why?
|
| Microscopy | 2 | 2011 | 64 | 0.170 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 14 | 0.170 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 202 | 0.170 |
Why?
|
| Biopsy | 3 | 2019 | 540 | 0.170 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 14 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 208 | 0.160 |
Why?
|
| Integrin beta1 | 1 | 2019 | 48 | 0.160 |
Why?
|
| Morphogenesis | 3 | 2017 | 159 | 0.160 |
Why?
|
| Cachexia | 1 | 2019 | 54 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2022 | 78 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 37 | 0.160 |
Why?
|
| HEK293 Cells | 5 | 2019 | 326 | 0.160 |
Why?
|
| Endometrium | 1 | 2018 | 31 | 0.160 |
Why?
|
| Protein Kinase C-alpha | 1 | 2018 | 24 | 0.160 |
Why?
|
| RNA Interference | 2 | 2017 | 266 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 7 | 2021 | 852 | 0.160 |
Why?
|
| Radiation Tolerance | 1 | 2018 | 30 | 0.160 |
Why?
|
| Chemokines | 2 | 2016 | 119 | 0.160 |
Why?
|
| Liver Regeneration | 1 | 2018 | 38 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 83 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.150 |
Why?
|
| Estrogens | 1 | 2019 | 173 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 209 | 0.150 |
Why?
|
| Enzyme Inhibitors | 6 | 2003 | 659 | 0.150 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 3 | 0.150 |
Why?
|
| Interleukin-11 | 1 | 2017 | 13 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 51 | 0.150 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 38 | 0.150 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2018 | 42 | 0.150 |
Why?
|
| Phosphoproteins | 4 | 2001 | 202 | 0.150 |
Why?
|
| Intestinal Neoplasms | 1 | 2017 | 30 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 2 | 6 | 2002 | 33 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2017 | 5 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 199 | 0.150 |
Why?
|
| Neoplasms, Experimental | 2 | 2017 | 118 | 0.150 |
Why?
|
| Interleukin-18 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2017 | 18 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 159 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 71 | 0.150 |
Why?
|
| Transcription Factor DP1 | 9 | 2000 | 11 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2018 | 682 | 0.150 |
Why?
|
| Cell Compartmentation | 2 | 2014 | 41 | 0.150 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2017 | 6 | 0.150 |
Why?
|
| Liposarcoma | 1 | 2017 | 13 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 17 | 0.150 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 64 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2019 | 222 | 0.150 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 123 | 0.150 |
Why?
|
| Interleukins | 1 | 2017 | 79 | 0.140 |
Why?
|
| Erythropoiesis | 2 | 2008 | 24 | 0.140 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 475 | 0.140 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 3 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 219 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 44 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2019 | 295 | 0.140 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2016 | 2 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2003 | 174 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 536 | 0.140 |
Why?
|
| Acinar Cells | 1 | 2016 | 8 | 0.140 |
Why?
|
| Palatine Tonsil | 2 | 2017 | 8 | 0.140 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 10 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 228 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 48 | 0.140 |
Why?
|
| Neoplasm Transplantation | 5 | 2019 | 160 | 0.140 |
Why?
|
| Tretinoin | 2 | 2000 | 92 | 0.140 |
Why?
|
| Protein Domains | 1 | 2016 | 74 | 0.140 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 76 | 0.140 |
Why?
|
| Giant Cells | 2 | 2013 | 14 | 0.140 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2016 | 41 | 0.130 |
Why?
|
| Adenoviridae | 7 | 2004 | 295 | 0.130 |
Why?
|
| CpG Islands | 2 | 2007 | 51 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2016 | 19 | 0.130 |
Why?
|
| Hemorrhagic Disorders | 1 | 1995 | 7 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 89 | 0.130 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 42 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 113 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2015 | 324 | 0.130 |
Why?
|
| Fibrinolysis | 1 | 1995 | 55 | 0.130 |
Why?
|
| Protein Conformation | 4 | 1992 | 362 | 0.130 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2015 | 4 | 0.130 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 25 | 0.130 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 12 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 39 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 44 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 23 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 5 | 2003 | 7 | 0.130 |
Why?
|
| Macromolecular Substances | 6 | 1996 | 122 | 0.130 |
Why?
|
| Retina | 2 | 2009 | 252 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 1995 | 123 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2015 | 16 | 0.120 |
Why?
|
| 3' Untranslated Regions | 2 | 2021 | 56 | 0.120 |
Why?
|
| Gene Library | 2 | 2005 | 68 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2019 | 195 | 0.120 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 61 | 0.120 |
Why?
|
| Placental Circulation | 1 | 2014 | 1 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 21 | 0.120 |
Why?
|
| Adenomatous Polyps | 1 | 2014 | 18 | 0.120 |
Why?
|
| Piperidones | 1 | 2014 | 2 | 0.120 |
Why?
|
| Body Patterning | 1 | 2014 | 44 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 18 | 0.120 |
Why?
|
| Hyperplasia | 2 | 2019 | 89 | 0.120 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 159 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2017 | 156 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 5 | 2001 | 38 | 0.110 |
Why?
|
| Aromatase | 2 | 2019 | 8 | 0.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 44 | 0.110 |
Why?
|
| Intestines | 1 | 2014 | 114 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 95 | 0.110 |
Why?
|
| Capillaries | 1 | 2014 | 105 | 0.110 |
Why?
|
| Precancerous Conditions | 2 | 2014 | 74 | 0.110 |
Why?
|
| Protein Isoforms | 3 | 2013 | 246 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2005 | 1083 | 0.110 |
Why?
|
| ErbB Receptors | 3 | 2022 | 239 | 0.110 |
Why?
|
| Chorionic Villi | 1 | 2013 | 5 | 0.110 |
Why?
|
| Frizzled Receptors | 1 | 2013 | 8 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 261 | 0.110 |
Why?
|
| Hematopoiesis | 3 | 2006 | 108 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2013 | 20 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 397 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 778 | 0.110 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2014 | 15 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 824 | 0.110 |
Why?
|
| Biomarkers, Tumor | 4 | 2021 | 508 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.100 |
Why?
|
| Structure-Activity Relationship | 5 | 1996 | 420 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2012 | 16 | 0.100 |
Why?
|
| Computational Biology | 1 | 2013 | 190 | 0.100 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 16 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 375 | 0.100 |
Why?
|
| E2F5 Transcription Factor | 3 | 2009 | 4 | 0.100 |
Why?
|
| Inactivation, Metabolic | 1 | 2011 | 28 | 0.100 |
Why?
|
| Xenobiotics | 1 | 2011 | 17 | 0.100 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 159 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2011 | 42 | 0.100 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 306 | 0.100 |
Why?
|
| Animals, Genetically Modified | 2 | 2012 | 63 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 65 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 126 | 0.100 |
Why?
|
| Point Mutation | 2 | 2010 | 97 | 0.100 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 493 | 0.100 |
Why?
|
| Cell Biology | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cytological Techniques | 1 | 2011 | 23 | 0.090 |
Why?
|
| Retinoblastoma | 2 | 2015 | 26 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 24 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 65 | 0.090 |
Why?
|
| CD11b Antigen | 1 | 2010 | 47 | 0.090 |
Why?
|
| Time Factors | 4 | 2015 | 4655 | 0.090 |
Why?
|
| Lung | 1 | 2015 | 849 | 0.090 |
Why?
|
| Lens, Crystalline | 2 | 2016 | 39 | 0.090 |
Why?
|
| Genes, ras | 1 | 2010 | 46 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2013 | 448 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Benzoxazines | 1 | 2009 | 20 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2009 | 27 | 0.090 |
Why?
|
| Antigens, CD34 | 4 | 2007 | 75 | 0.090 |
Why?
|
| Naphthalenes | 1 | 2009 | 47 | 0.090 |
Why?
|
| Morpholines | 1 | 2009 | 79 | 0.090 |
Why?
|
| Virion | 4 | 1994 | 31 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 150 | 0.080 |
Why?
|
| Retinoblastoma-Like Protein p130 | 4 | 2007 | 7 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 147 | 0.080 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 68 | 0.080 |
Why?
|
| Biomarkers | 3 | 2012 | 1593 | 0.080 |
Why?
|
| Peripheral Nervous System | 1 | 2008 | 12 | 0.080 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2009 | 65 | 0.080 |
Why?
|
| Cannabinoids | 1 | 2009 | 90 | 0.080 |
Why?
|
| Dimerization | 2 | 2008 | 99 | 0.080 |
Why?
|
| Models, Animal | 2 | 2007 | 252 | 0.080 |
Why?
|
| Neurogenesis | 2 | 2022 | 32 | 0.080 |
Why?
|
| Neurons | 2 | 2007 | 881 | 0.080 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2008 | 3 | 0.080 |
Why?
|
| Heterografts | 2 | 2019 | 70 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 92 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2019 | 237 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2007 | 163 | 0.080 |
Why?
|
| Computer Graphics | 1 | 2008 | 37 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 322 | 0.080 |
Why?
|
| Eye | 1 | 2008 | 89 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 142 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 25 | 0.080 |
Why?
|
| Neoplasm Grading | 2 | 2018 | 111 | 0.080 |
Why?
|
| Blast Crisis | 1 | 2007 | 7 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 2007 | 24 | 0.080 |
Why?
|
| Placenta Diseases | 1 | 2007 | 5 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2007 | 37 | 0.070 |
Why?
|
| Amacrine Cells | 1 | 2007 | 1 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2007 | 19 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 20 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2002 | 376 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2002 | 742 | 0.070 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2006 | 8 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 13 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 107 | 0.070 |
Why?
|
| Prognosis | 3 | 2021 | 2093 | 0.070 |
Why?
|
| Gene Duplication | 1 | 2006 | 12 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 786 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2003 | 251 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2021 | 238 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 3 | 2014 | 183 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2011 | 447 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2021 | 294 | 0.060 |
Why?
|
| E2F6 Transcription Factor | 1 | 2005 | 2 | 0.060 |
Why?
|
| Collagen | 2 | 2019 | 636 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 166 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 43 | 0.060 |
Why?
|
| Image Enhancement | 3 | 2011 | 143 | 0.060 |
Why?
|
| Restriction Mapping | 5 | 2004 | 85 | 0.060 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2004 | 71 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2016 | 124 | 0.060 |
Why?
|
| Dinucleoside Phosphates | 1 | 2003 | 2 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2003 | 21 | 0.050 |
Why?
|
| Horses | 1 | 2003 | 20 | 0.050 |
Why?
|
| Calcitonin | 1 | 2003 | 21 | 0.050 |
Why?
|
| Helminth Proteins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Vulva | 1 | 2022 | 6 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2003 | 46 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 492 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2009 | 312 | 0.050 |
Why?
|
| ras-GRF1 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2002 | 10 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2022 | 61 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2022 | 95 | 0.050 |
Why?
|
| Rabbits | 3 | 2001 | 509 | 0.050 |
Why?
|
| Diet, Western | 1 | 2022 | 17 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 40 | 0.050 |
Why?
|
| Threonine | 1 | 2022 | 47 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 222 | 0.050 |
Why?
|
| AU Rich Elements | 1 | 2021 | 1 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 27 | 0.050 |
Why?
|
| Interleukin-15 | 2 | 2017 | 66 | 0.050 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 3 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 39 | 0.050 |
Why?
|
| Karyopherins | 1 | 2021 | 11 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2001 | 54 | 0.050 |
Why?
|
| Megakaryocytes | 1 | 2001 | 18 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 329 | 0.050 |
Why?
|
| Glycosylation | 1 | 2022 | 185 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 55 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2001 | 24 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2021 | 29 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 317 | 0.050 |
Why?
|
| RNA Stability | 1 | 2021 | 55 | 0.050 |
Why?
|
| Mammalian orthoreovirus 3 | 2 | 1991 | 3 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
| Amifostine | 1 | 2001 | 3 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 100 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2001 | 53 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 138 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 85 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 22 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2001 | 27 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 37 | 0.050 |
Why?
|
| Adenovirus E2 Proteins | 1 | 2000 | 1 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 284 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Gamma Rays | 2 | 2018 | 64 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 304 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2001 | 384 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 300 | 0.050 |
Why?
|
| DNA Repair | 1 | 2001 | 127 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2001 | 33 | 0.050 |
Why?
|
| Actins | 2 | 2014 | 249 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 179 | 0.050 |
Why?
|
| Caspases | 1 | 2001 | 194 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2001 | 63 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 1753 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2001 | 233 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2000 | 37 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 2007 | 95 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 266 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 214 | 0.040 |
Why?
|
| Cell Death | 1 | 2001 | 329 | 0.040 |
Why?
|
| Histones | 2 | 2013 | 111 | 0.040 |
Why?
|
| Dendritic Cells | 2 | 2017 | 201 | 0.040 |
Why?
|
| Cell-Free System | 2 | 1996 | 43 | 0.040 |
Why?
|
| Leukemia | 1 | 2000 | 117 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2019 | 8 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 31 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 411 | 0.040 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 12 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 546 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2015 | 254 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 2077 | 0.040 |
Why?
|
| Genes, cdc | 1 | 1999 | 5 | 0.040 |
Why?
|
| Corticosterone | 1 | 2019 | 51 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1997 | 272 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 85 | 0.040 |
Why?
|
| Adult | 5 | 2018 | 21403 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 97 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 304 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1070 | 0.040 |
Why?
|
| Minichromosome Maintenance Complex Component 3 | 1 | 1998 | 1 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 84 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 301 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2001 | 499 | 0.040 |
Why?
|
| Prostate | 1 | 2019 | 116 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2019 | 99 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 110 | 0.040 |
Why?
|
| Ectopic Gene Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 67 | 0.040 |
Why?
|
| Pregnancy, Animal | 2 | 2008 | 27 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2018 | 41 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1998 | 69 | 0.040 |
Why?
|
| Plasmids | 4 | 2004 | 258 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2001 | 296 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2011 | 384 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 434 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 19 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 21147 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 48 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 34 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 47 | 0.040 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1997 | 29 | 0.040 |
Why?
|
| DNA Probes | 1 | 1997 | 57 | 0.040 |
Why?
|
| Models, Structural | 2 | 1994 | 22 | 0.040 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1996 | 11 | 0.040 |
Why?
|
| Autoradiography | 1 | 1997 | 94 | 0.040 |
Why?
|
| Receptor, Notch3 | 1 | 2016 | 2 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1996 | 24 | 0.040 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 5 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1991 | 358 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 30 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 25 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2016 | 71 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 30 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 68 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 714 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 396 | 0.030 |
Why?
|
| Mitochondria | 1 | 2001 | 643 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 286 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1996 | 105 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 89 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 71 | 0.030 |
Why?
|
| Thromboplastin | 1 | 1995 | 21 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1995 | 33 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 206 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1995 | 26 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1996 | 81 | 0.030 |
Why?
|
| Aprotinin | 1 | 1995 | 55 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 800 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2015 | 5 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 173 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 382 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 302 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 26 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 626 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 247 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 29 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2014 | 25 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2014 | 15 | 0.030 |
Why?
|
| Trypsin | 2 | 1991 | 64 | 0.030 |
Why?
|
| Symporters | 1 | 2014 | 27 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 2 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2014 | 45 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2014 | 66 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 27 | 0.030 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2013 | 6 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 98 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 161 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 52 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 80 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 765 | 0.030 |
Why?
|
| Tumor Escape | 1 | 1973 | 37 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2013 | 3 | 0.030 |
Why?
|
| Luciferases | 2 | 2004 | 105 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 88 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 219 | 0.030 |
Why?
|
| Markov Chains | 1 | 2013 | 133 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1553 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 38 | 0.030 |
Why?
|
| Brain | 2 | 2020 | 2176 | 0.030 |
Why?
|
| Cyclin A | 2 | 2004 | 11 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 81 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2007 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1995 | 296 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 248 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cell Separation | 2 | 2004 | 132 | 0.030 |
Why?
|
| Cell Membrane | 1 | 1994 | 525 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 7 | 0.030 |
Why?
|
| bcl-X Protein | 2 | 2003 | 36 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 27 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2012 | 29 | 0.030 |
Why?
|
| S100 Calcium Binding Protein A7 | 1 | 2011 | 4 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2012 | 110 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2012 | 97 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2011 | 38 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2011 | 19 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 155 | 0.020 |
Why?
|
| Alternative Splicing | 2 | 2002 | 93 | 0.020 |
Why?
|
| Bromodeoxyuridine | 2 | 2002 | 37 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 1991 | 4 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 72 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 1991 | 17 | 0.020 |
Why?
|
| Zebrafish | 1 | 2012 | 187 | 0.020 |
Why?
|
| Bone Marrow | 2 | 2003 | 168 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 34 | 0.020 |
Why?
|
| Ions | 1 | 1991 | 50 | 0.020 |
Why?
|
| Solubility | 1 | 1991 | 134 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 230 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 627 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1991 | 110 | 0.020 |
Why?
|
| NIMA-Related Kinases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2010 | 7 | 0.020 |
Why?
|
| Virus Replication | 1 | 1991 | 104 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1991 | 175 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 396 | 0.020 |
Why?
|
| Paxillin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Zinostatin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2009 | 6 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 27 | 0.020 |
Why?
|
| Bone Marrow Cells | 2 | 2001 | 217 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 64 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2009 | 52 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 94 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 64 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 134 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 47 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2009 | 18 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 370 | 0.020 |
Why?
|
| Chimera | 1 | 2009 | 33 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 88 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 82 | 0.020 |
Why?
|
| G2 Phase | 2 | 2001 | 26 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5731 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2009 | 13 | 0.020 |
Why?
|
| Fetal Death | 1 | 2009 | 49 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2009 | 20 | 0.020 |
Why?
|
| Neuroglia | 1 | 2009 | 136 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 160 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 119 | 0.020 |
Why?
|
| Edema | 1 | 2009 | 66 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 110 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2009 | 64 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2009 | 102 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2002 | 181 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2009 | 231 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 47 | 0.020 |
Why?
|
| Camptothecin | 1 | 2008 | 39 | 0.020 |
Why?
|
| Enterocytes | 1 | 2007 | 7 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 93 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2007 | 32 | 0.020 |
Why?
|
| Transgenes | 1 | 2007 | 92 | 0.020 |
Why?
|
| Telencephalon | 1 | 2007 | 6 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 866 | 0.020 |
Why?
|
| Adolescent | 2 | 2001 | 8912 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 7029 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2009 | 328 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2006 | 19 | 0.020 |
Why?
|
| Ribs | 1 | 2006 | 25 | 0.020 |
Why?
|
| Rats | 3 | 2000 | 5300 | 0.020 |
Why?
|
| Interneurons | 1 | 2007 | 70 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 33 | 0.020 |
Why?
|
| Surface Properties | 1 | 2007 | 363 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2007 | 230 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 333 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 3259 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2004 | 3 | 0.020 |
Why?
|
| Erythroblasts | 1 | 2004 | 4 | 0.020 |
Why?
|
| U937 Cells | 1 | 2004 | 61 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 8 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2004 | 14 | 0.020 |
Why?
|
| Retroviridae | 1 | 2004 | 29 | 0.020 |
Why?
|
| Genome, Human | 1 | 2004 | 62 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 3 | 1 | 2004 | 2 | 0.010 |
Why?
|
| Growth Differentiation Factor 10 | 1 | 2004 | 2 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 40 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 189 | 0.010 |
Why?
|
| Aged | 2 | 2001 | 14862 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cyclin A2 | 1 | 2004 | 3 | 0.010 |
Why?
|
| Cyclin B | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cyclin B1 | 1 | 2004 | 7 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 191 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2003 | 3 | 0.010 |
Why?
|
| Eye Abnormalities | 1 | 2004 | 15 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 160 | 0.010 |
Why?
|
| Sulfites | 1 | 2003 | 7 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 11 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 95 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 196 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 617 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 255 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 282 | 0.010 |
Why?
|
| Muridae | 1 | 2002 | 9 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2003 | 67 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 11 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 60 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 68 | 0.010 |
Why?
|
| Testis | 1 | 2002 | 37 | 0.010 |
Why?
|
| Genes | 1 | 2002 | 86 | 0.010 |
Why?
|
| Thymidine | 1 | 2002 | 32 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 122 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 90 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2002 | 34 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 12 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 197 | 0.010 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2001 | 3 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 2001 | 3 | 0.010 |
Why?
|
| Reticulocytes | 1 | 2001 | 7 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2001 | 7 | 0.010 |
Why?
|
| Thrombopoietin | 1 | 2001 | 15 | 0.010 |
Why?
|
| Quinones | 1 | 2001 | 13 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2001 | 13 | 0.010 |
Why?
|
| Reed-Sternberg Cells | 1 | 2001 | 1 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 155 | 0.010 |
Why?
|
| Genes, Viral | 2 | 1991 | 44 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1991 | 41 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2001 | 25 | 0.010 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2001 | 13 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2001 | 24 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2001 | 35 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 241 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2000 | 29 | 0.010 |
Why?
|
| Cisplatin | 1 | 2001 | 192 | 0.010 |
Why?
|
| Laminin | 1 | 2000 | 62 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2000 | 9 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 144 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 475 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 446 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1056 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2001 | 68 | 0.010 |
Why?
|
| Acute Disease | 1 | 2001 | 658 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2001 | 330 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 258 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 191 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 20 | 0.010 |
Why?
|
| Half-Life | 1 | 1999 | 96 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 1047 | 0.010 |
Why?
|
| Flavonoids | 1 | 1999 | 109 | 0.010 |
Why?
|
| Ubiquitins | 1 | 1998 | 22 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1998 | 24 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1998 | 82 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7277 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1998 | 152 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1996 | 24 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 173 | 0.010 |
Why?
|
| Pepsin A | 1 | 1994 | 8 | 0.010 |
Why?
|
| Capsid | 1 | 1994 | 8 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1994 | 27 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 136 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1973 | 13 | 0.010 |
Why?
|
| Mice, Inbred NZB | 1 | 1973 | 37 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1973 | 25 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1973 | 25 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1973 | 55 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1973 | 37 | 0.010 |
Why?
|
| Epitopes | 1 | 1973 | 146 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1973 | 132 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1973 | 114 | 0.010 |
Why?
|
| Autoimmunity | 1 | 1973 | 118 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1991 | 36 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 79 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1991 | 60 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 73 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1991 | 11 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 35 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1990 | 204 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1991 | 483 | 0.010 |
Why?
|